Download | March 6, 2013
Development Services: Low Solubility Compounds
Source: Patheon Inc.A small biotech company contracted Patheon to design an oral solid formulation and supply material for Phase I clinical studies for a high dose insoluble drug. Minimal quantities of this drug were available and its stability was unknown.
